Approval · Notice of Compliance 19622 · 2017
SIMPONI: Notice of Compliance 19622
Issued August 4, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19622
- Date
- August 4, 2017
- Company
- Janssen Inc.Toronto, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Additional drug product manufacturing site
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SIMPONI | Not yet assigned | — |